Targeting HER3 for cancer treatment: a new horizon for an old target
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference49 articles.
1. ErbB receptors and signaling pathways in cancer;Hynes;Curr Opin Cell Biol,2009
2. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A. 86(23):9193-9197.
3. An open-and-shut case? recent insights into the activation of EGF/ErbB receptors;Burgess;Mol Cell,2003
4. Neuregulins and cancer;Montero;Clin Cancer Res,2008
5. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3;Jura;Proc Natl Acad Sci USA,2009
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel antibody-drug conjugates based on DXd-ADC technology;Bioorganic Chemistry;2024-10
2. Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases;Drug Resistance Updates;2024-09
3. Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development;Cancer Treatment Reviews;2024-09
4. Antibody–drug conjugates for breast cancer: a bibliometric study and clinical trial analysis;Discover Oncology;2024-08-02
5. Unlocking the potential of bispecific ADCs for targeted cancer therapy;Frontiers of Medicine;2024-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3